Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Sep 15;342(Pt 3):677–682.

Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro.

N B Weksler 1, G P Lunstrum 1, E S Reid 1, W A Horton 1
PMCID: PMC1220509  PMID: 10477279

Abstract

Fibroblast growth factor (FGF) 9 was compared with FGF2 in its ability to influence proliferation, differentiation, terminal differentiation and apoptosis in a rat calvaria-derived cell line (RCJ 3.1C5.18) that spontaneously undergoes chondrocyte differentiation in vitro. Like FGF2, FGF9 promoted proliferation, but to a lesser extent. In contrast to FGF2, which blocked chondrocytic differentiation, FGF9 had no effect on differentiation but inhibited terminal differentiation. FGF9 also stimulated expression of the mitotic inhibitor p21 to a greater extent than FGF2. Neither ligand influenced apoptosis. The results indicate that FGF9 could account for many of the physiological responses attributed to FGF-receptor activation in the growth plate.

Full Text

The Full Text of this article is available as a PDF (150.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellus G. A., McIntosh I., Smith E. A., Aylsworth A. S., Kaitila I., Horton W. A., Greenhaw G. A., Hecht J. T., Francomano C. A. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet. 1995 Jul;10(3):357–359. doi: 10.1038/ng0795-357. [DOI] [PubMed] [Google Scholar]
  2. Bonneh-Barkay D., Shlissel M., Berman B., Shaoul E., Admon A., Vlodavsky I., Carey D. J., Asundi V. K., Reich-Slotky R., Ron D. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem. 1997 May 9;272(19):12415–12421. doi: 10.1074/jbc.272.19.12415. [DOI] [PubMed] [Google Scholar]
  3. Coffin J. D., Florkiewicz R. Z., Neumann J., Mort-Hopkins T., Dorn G. W., 2nd, Lightfoot P., German R., Howles P. N., Kier A., O'Toole B. A. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell. 1995 Dec;6(12):1861–1873. doi: 10.1091/mbc.6.12.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colvin J. S., Bohne B. A., Harding G. W., McEwen D. G., Ornitz D. M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet. 1996 Apr;12(4):390–397. doi: 10.1038/ng0496-390. [DOI] [PubMed] [Google Scholar]
  5. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 1996 Mar 22;84(6):911–921. doi: 10.1016/s0092-8674(00)81069-7. [DOI] [PubMed] [Google Scholar]
  6. Di Cunto F., Topley G., Calautti E., Hsiao J., Ong L., Seth P. K., Dotto G. P. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science. 1998 May 15;280(5366):1069–1072. doi: 10.1126/science.280.5366.1069. [DOI] [PubMed] [Google Scholar]
  7. DiGabriele A. D., Lax I., Chen D. I., Svahn C. M., Jaye M., Schlessinger J., Hendrickson W. A. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature. 1998 Jun 25;393(6687):812–817. doi: 10.1038/31741. [DOI] [PubMed] [Google Scholar]
  8. Grigoriadis A. E., Heersche J. N., Aubin J. E. Analysis of chondroprogenitor frequency and cartilage differentiation in a novel family of clonal chondrogenic rat cell lines. Differentiation. 1996 Sep;60(5):299–307. doi: 10.1046/j.1432-0436.1996.6050299.x. [DOI] [PubMed] [Google Scholar]
  9. Grigoriadis A. E., Heersche J. N., Aubin J. E. Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Dev Biol. 1990 Dec;142(2):313–318. doi: 10.1016/0012-1606(90)90352-j. [DOI] [PubMed] [Google Scholar]
  10. Hecht D., Zimmerman N., Bedford M., Avivi A., Yayon A. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. Growth Factors. 1995;12(3):223–233. doi: 10.3109/08977199509036882. [DOI] [PubMed] [Google Scholar]
  11. Hill D. J., Logan A., De Sousa D. Stimulation of DNA and protein synthesis in epiphyseal growth plate chondrocytes by fibroblast growth factors. Interactions with other peptide growth factors. Ann N Y Acad Sci. 1991;638:449–452. doi: 10.1111/j.1749-6632.1991.tb49066.x. [DOI] [PubMed] [Google Scholar]
  12. Horton W. A. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr. 1997 Aug;9(4):437–442. doi: 10.1097/00008480-199708000-00021. [DOI] [PubMed] [Google Scholar]
  13. Horton W. A., Hood O. J., Machado M. A., Ahmed S., Griffey E. S. Abnormal ossification in thanatophoric dysplasia. Bone. 1988;9(1):53–61. doi: 10.1016/8756-3282(88)90027-0. [DOI] [PubMed] [Google Scholar]
  14. Inoue H., Kato Y., Iwamoto M., Hiraki Y., Sakuda M., Suzuki F. Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. J Cell Physiol. 1989 Feb;138(2):329–337. doi: 10.1002/jcp.1041380216. [DOI] [PubMed] [Google Scholar]
  15. Jacks T., Weinberg R. A. The expanding role of cell cycle regulators. Science. 1998 May 15;280(5366):1035–1036. doi: 10.1126/science.280.5366.1035. [DOI] [PubMed] [Google Scholar]
  16. Jingushi S., Scully S. P., Joyce M. E., Sugioka Y., Bolander M. E. Transforming growth factor-beta 1 and fibroblast growth factors in rat growth plate. J Orthop Res. 1995 Sep;13(5):761–768. doi: 10.1002/jor.1100130516. [DOI] [PubMed] [Google Scholar]
  17. Johnson D. E., Williams L. T. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993;60:1–41. doi: 10.1016/s0065-230x(08)60821-0. [DOI] [PubMed] [Google Scholar]
  18. Kato Y., Gospodarowicz D. Sulfated proteoglycan synthesis by confluent cultures of rabbit costal chondrocytes grown in the presence of fibroblast growth factor. J Cell Biol. 1985 Feb;100(2):477–485. doi: 10.1083/jcb.100.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kato Y., Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem. 1990 Apr 5;265(10):5903–5909. [PubMed] [Google Scholar]
  20. Kim H. J., Rice D. P., Kettunen P. J., Thesleff I. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development. 1998 Apr;125(7):1241–1251. doi: 10.1242/dev.125.7.1241. [DOI] [PubMed] [Google Scholar]
  21. Leach R. M., Jr, Sokol C., McMurtry J. P. Immunolocalization of basic fibroblast growth factor in porcine epiphyseal growth plate. Domest Anim Endocrinol. 1997 Mar;14(2):129–132. doi: 10.1016/s0739-7240(96)00120-8. [DOI] [PubMed] [Google Scholar]
  22. Legeai-Mallet L., Benoist-Lasselin C., Delezoide A. L., Munnich A., Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem. 1998 May 22;273(21):13007–13014. doi: 10.1074/jbc.273.21.13007. [DOI] [PubMed] [Google Scholar]
  23. Lunstrum G. P., Keene D. R., Weksler N. B., Cho Y. J., Cornwall M., Horton W. A. Chondrocyte differentiation in a rat mesenchymal cell line. J Histochem Cytochem. 1999 Jan;47(1):1–6. doi: 10.1177/002215549904700101. [DOI] [PubMed] [Google Scholar]
  24. Mancilla E. E., De Luca F., Uyeda J. A., Czerwiec F. S., Baron J. Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology. 1998 Jun;139(6):2900–2904. doi: 10.1210/endo.139.6.6032. [DOI] [PubMed] [Google Scholar]
  25. Martin G. R. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 1998 Jun 1;12(11):1571–1586. doi: 10.1101/gad.12.11.1571. [DOI] [PubMed] [Google Scholar]
  26. Nagai H., Tsukuda R., Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone. 1995 Mar;16(3):367–373. doi: 10.1016/8756-3282(94)00049-2. [DOI] [PubMed] [Google Scholar]
  27. Ornitz D. M., Xu J., Colvin J. S., McEwen D. G., MacArthur C. A., Coulier F., Gao G., Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996 Jun 21;271(25):15292–15297. doi: 10.1074/jbc.271.25.15292. [DOI] [PubMed] [Google Scholar]
  28. Peters K. G., Werner S., Chen G., Williams L. T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 1992 Jan;114(1):233–243. doi: 10.1242/dev.114.1.233. [DOI] [PubMed] [Google Scholar]
  29. Peters K., Ornitz D., Werner S., Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol. 1993 Feb;155(2):423–430. doi: 10.1006/dbio.1993.1040. [DOI] [PubMed] [Google Scholar]
  30. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell. 1995 Nov 3;83(3):357–360. doi: 10.1016/0092-8674(95)90112-4. [DOI] [PubMed] [Google Scholar]
  31. Sherman L., Wainwright D., Ponta H., Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev. 1998 Apr 1;12(7):1058–1071. doi: 10.1101/gad.12.7.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sherr C. J. G1 phase progression: cycling on cue. Cell. 1994 Nov 18;79(4):551–555. doi: 10.1016/0092-8674(94)90540-1. [DOI] [PubMed] [Google Scholar]
  33. Shiang R., Thompson L. M., Zhu Y. Z., Church D. M., Fielder T. J., Bocian M., Winokur S. T., Wasmuth J. J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994 Jul 29;78(2):335–342. doi: 10.1016/0092-8674(94)90302-6. [DOI] [PubMed] [Google Scholar]
  34. Su W. C., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J., Deng C., Horton W. A., Fu X. Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 1997 Mar 20;386(6622):288–292. doi: 10.1038/386288a0. [DOI] [PubMed] [Google Scholar]
  35. Tavormina P. L., Shiang R., Thompson L. M., Zhu Y. Z., Wilkin D. J., Lachman R. S., Wilcox W. R., Rimoin D. L., Cohn D. H., Wasmuth J. J. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995 Mar;9(3):321–328. doi: 10.1038/ng0395-321. [DOI] [PubMed] [Google Scholar]
  36. Trippel S. B., Wroblewski J., Makower A. M., Whelan M. C., Schoenfeld D., Doctrow S. R. Regulation of growth-plate chondrocytes by insulin-like growth-factor I and basic fibroblast growth factor. J Bone Joint Surg Am. 1993 Feb;75(2):177–189. doi: 10.2106/00004623-199302000-00004. [DOI] [PubMed] [Google Scholar]
  37. Wroblewski J., Edwall-Arvidsson C. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J Bone Miner Res. 1995 May;10(5):735–742. doi: 10.1002/jbmr.5650100510. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES